Skip to content

Clinical study of remazolam toluenesulfonate, propofol and midazolam for early goal directed sedation in patients with septic shock

Clinical study of remazolam toluenesulfonate, propofol and midazolam for early goal directed sedation in patients with septic shock

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067651
Enrollment
Unknown
Registered
2023-01-16
Start date
2023-01-16
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

remazolam toluenesulfonate:remazolam toluenesulfonate,

Sponsors

Department of Critical Care Medicine, Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)age >= 18 years old; (2) it meets the diagnostic criteria for septic shock according to the International Guidelines for Management of Sepsis and Septic Shock(2016); (3) invasive mechanical ventilation is required; (4)obtain informed consent from patients or their family members

Exclusion criteria

Exclusion criteria: (1) patients who have undergone invasive mechanical ventilation and used sedative drugs at admission; (2) those with other types of shock; (3) pregnant and nursing women ; (4) death is expected in the short term; (5) those using muscle relaxants; (6)patients with alcoholism or mental disorders or severe cognitive impairment; (7) patients with neuromuscular disorders; (8) patients with severe liver and kidney insufficiency; (9) patients with hypotension whose hemodynamics are still unstable maintained with vasoactive drugs; (10) Patients with acute myocardial infarction and severe heart failure (NYHA grade IV); (11) Patients who are allergic to remiazolam toluenesulfonate, propofol and midazolam.

Design outcomes

Primary

MeasureTime frame
RASS score;

Secondary

MeasureTime frame
time to reach target sedation level;The rate of reaching target sedation within 8 hours of sedation treatment;Total amount of vasoactive drugs used within 8 hours of sedative treatment;Adverse reaction rate;Waking time;MODS incidence;Delirium incidence;Time of invasive ventilation;case fatality rate in ICU,;blood gas;

Countries

China

Contacts

Public ContactChangyong Wang

Department of Critical Care Medicine, Renmin Hospital of Wuhan University

wcywhu@sina.com+86 136 9732 9672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026